Evidence map›Paper›PMID 25072244›Full record

ArticlePloS one2014

Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?

Carmen Ferrajolo, Vincenzo Arcoraci, Maria Giuseppa Sullo, Concetta Rafaniello, Liberata Sportiello, Rosarita Ferrara, Angelo Cannata, Claudia Pagliaro, Michele Giuseppe Tari, Achille Patrizio Caputi and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Lipid-lowering drug prescriptions in a group of Colombian patients.Biomedica : revista del Instituto Nacional de Salud · 2019
    Article
  7. Observational
  8. Article
  9. Evaluation of statin utilization in the Republic of Macedonia during 2013-2016.ClinicoEconomics and outcomes research : CEOR · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Carmen FerrajoloCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy; Medical Informatics Department, Erasmus University Medical Centre, Rotterdam, Netherlands.
Vincenzo ArcoraciClinical and Experimental Medicine Department, University of Messina, Messina, Italy.
Maria Giuseppa SulloCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy.
Concetta RafanielloCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy.
Liberata SportielloCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy.
Rosarita FerraraClinical and Experimental Medicine Department, University of Messina, Messina, Italy.
Angelo CannataClinical and Experimental Medicine Department, University of Messina, Messina, Italy.
Claudia PagliaroLocal Health Unit of Caserta, Caserta, Italy.
Michele Giuseppe TariLocal Health Unit of Caserta, Caserta, Italy.
Achille Patrizio CaputiMedical Informatics Department, Erasmus University Medical Centre, Rotterdam, Netherlands.
Francesco RossiCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy.
Gianluca TrifiròMedical Informatics Department, Erasmus University Medical Centre, Rotterdam, Netherlands; Clinical and Experimental Medicine Department, University of Messina, Messina, Italy.
Annalisa CapuanoCampania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Experimental Medicine Department, Pharmacology Section, Second University of Naples, Naples, Italy.
University of Campania "Luigi Vanvitelli" · ITUniversity of Messina · ITRegione Campania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe sought to evaluate the prescribing pattern of statins according to national and regional health policy interventions and to assess specifically the adherence to the therapy in outpatient setting in Southern Italy.

methodsA population-based study was performed on persons ≥15 years old, living in the catchment area of Caserta (Southern Italy), and registered in Arianna database between 2004 and 2010. Prevalence and incidence of new treatments with statins were calculated for each year and stratified by drug. Adherence to therapy was measured by Medication Possession Ratio. Sub-analyses by individual compound and type of cardiovascular prevention were performed.

resultsFrom 2004 to 2010, the one-year prevalence of statin use increased from 44.9/1,000 inhabitants to 79.8/1,000, respectively, consistently with the incidence of new use from 16.2/1,000 to 19.5/1,000, except a slight decrease after criteria reimbursement revision on 2005 (13.3/1,000). The incidence of new treatments decreased for atorvastatin, and increased for simvastatin over the study years. Overall, 43% of new users were still highly adherent to the treatment (MPR≥80%) after six months, while 26% after 4-years of follow-up. As compared with highly adherent patients, the probability to be non-adherent (MPR≤25%) at 4-years of follow-up was 26% higher for women than for men (full adj. odds ratio: 1.26; 95% CI: 1.10-1.45), and 64% higher in patients who started on primary rather than on secondary prevention (1.64; 1.29-2.07).

conclusionsPrevalence and incidence of statin use increased consistently with health policy interventions. Only one-fourth of patients who newly initiated a statin were adherent to the treatment after 4-year of follow-up. Since the benefits of statins in terms of cardiovascular outcome and costs are associated with their chronic use, the identification of patient-related predictors of non-adherence such as gender, primary prevention could be suitable for physicians to improve the patients' compliance.

Indexed as

Drug Utilization ReviewHydroxymethylglutaryl-CoA Reductase InhibitorsPublic Health SurveillanceAdolescentAdultAgedDatabases, FactualFemaleFollow-Up StudiesHumansIncidenceItalyMaleMedication AdherenceMiddle AgedPrescriptionsHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID25072244
PMCPMC4114740
OpenAlexW2023703506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.